PRESS RELEASE published on 12/03/2024 at 10:38, 1 year 3 months ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL Sartorius Stedim Biotech SA in Aubagne, France declares total shares and voting rights as of November 30, 2024 Voting Rights Shares Sartorius Stedim Biotech France Aubagne
PRESS RELEASE published on 12/03/2024 at 10:38, 1 year 3 months ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL Sartorius Stedim Biotech SA declares number of shares and voting rights in the issued capital as per regulatory requirements Voting Rights Shares Sartorius Stedim Biotech AMF Regulations French Regulatory News
BRIEF published on 11/04/2024 at 10:16, 1 year 4 months ago Sartorius Stedim Biotech Statement on Shares and Voting Rights Share Capital Voting Rights Actions AMF Sartorius Stedim
PRESS RELEASE published on 11/04/2024 at 10:11, 1 year 4 months ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL Sartorius Stedim Biotech SA declares the number of shares and voting rights in the issued capital. Total shares: 97,330,405. Total voting rights: 165,567,396 Voting Rights Shares Sartorius Stedim Biotech Issued Capital French Regulatory News
BRIEF published on 10/17/2024 at 07:07, 1 year 5 months ago Sartorius Stedim Biotech: Unaudited results for the first nine months of 2024 Financial Results Sartorius Stedim Biotech Outlook 2024 Advanced Therapies Turnover
PRESS RELEASE published on 10/17/2024 at 07:02, 1 year 5 months ago Sartorius Stedim Biotech publishes unaudited results for the first nine months of 2024 Sartorius Stedim Biotech posts unaudited 9-month results for 2024, confirming outlook. Sales revenue 2,029 million euros, EBITDA 565 million euros, strong consumables demand EBITDA Sartorius Stedim Biotech Sales Revenue 9-month Figures Consumables
BRIEF published on 10/01/2024 at 11:19, 1 year 5 months ago Statement on the number of shares and voting rights at Sartorius Stedim Biotech Share Capital Voting Rights Actions Sartorius Stedim Biotech Regulatory
PRESS RELEASE published on 10/01/2024 at 11:15, 1 year 5 months ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL Press release regarding the declaration of the number of shares and voting rights of Sartorius Stedim Biotech S.A. in France Voting Rights Capital Shares Sartorius Stedim Biotech France
PRESS RELEASE published on 10/01/2024 at 11:14, 1 year 5 months ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL Sartorius Stedim Biotech SA declares number of shares and voting rights making up the issued capital. Details according to French regulations Voting Rights Shares French Regulations Sartorius Stedim Biotech Issued Capital
BRIEF published on 09/03/2024 at 10:20, 1 year 6 months ago Sartorius Stedim Biotech SA Announces Number of Shares and Voting Rights Voting Rights Shares Issued Capital Regulatory News Sartorius Stedim
Published on 03/23/2026 at 22:00, 20 minutes ago Hillcrest Participates in APEC 2026 and Announces Shares for Debt Offering
Published on 03/23/2026 at 21:18, 1 hour 2 minutes ago Amdocs Announces Appointment of Shimie Hortig to the Board of Directors Upon Shuky Sheffer's Retirement as Director and Chief Executive Officer
Published on 03/23/2026 at 14:05, 8 hours 15 minutes ago Wellgistics Health Inc. Signs $105,000,000 Letter of Intent to Evaluate Potential Acquisition of Neuritek Therapeutics, Inc. which is Pioneering Innovative Therapies for Neurological and Psychiatric Disorders
Published on 03/23/2026 at 14:00, 8 hours 20 minutes ago BlackBerry AtHoc Advances Command Center for Faster Response and Tighter Control During Critical Operations
Published on 03/23/2026 at 13:05, 9 hours 15 minutes ago SouthGobi Announces Disclosable and Connected Transaction Deferral of Payment Obligations Under Convertible Debenture and Amended and Restated Cooperation Agreement
Published on 03/23/2026 at 22:05, 14 minutes ago DeFi Technologies Provides Update on Timing of Annual Filings
Published on 03/23/2026 at 21:05, 1 hour 15 minutes ago Abivax Announces Full Year 2025 Financial Results and Provides Business Updates
Published on 03/23/2026 at 21:00, 1 hour 19 minutes ago Persistent Appoints Ruchi Kulhari as Executive Vice President - Enterprise Strategy & Execution
Published on 03/23/2026 at 20:55, 1 hour 24 minutes ago Ordering Both ESR and CRP Lab Tests Could Save Hospitals Millions Per Year -- New Study Challenges Notion the Tests are Interchangeable
Published on 03/23/2026 at 19:08, 3 hours 11 minutes ago Reporting on share buyback transactions carried out between March 16 and March 20, 2026
Published on 03/23/2026 at 17:45, 4 hours 34 minutes ago ENGIE will build, own and operate its largest onshore wind farm worldwide in Egypt
Published on 03/23/2026 at 17:45, 4 hours 35 minutes ago Share buyback for allocation to employees or corporate officers
Published on 03/23/2026 at 17:35, 4 hours 45 minutes ago Disclosure of transactions in own shares from March 16 to March 20, 2026
